These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6031976)

  • 1. [Effect of certain anticoagulant drugs on coronary flow in situ].
    Banaszkiewicz W; Kubacki A; Mrozikiewicz A
    Acta Physiol Pol; 1967; 18(1):117-20. PubMed ID: 6031976
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of some anticoagulant agents on coronary blood flow].
    Banaszkiewicz W; Kubacki A; Mrozikiewicz A
    Acta Physiol Pol; 1965; 16(6):917-21. PubMed ID: 4161745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of some inhibitors of monoamineoxidase activity on coronary flow. II. Effect on coronary vessels in studies in situ].
    Banaszkiewicz W; Chodera A
    Acta Physiol Pol; 1967; 18(5):811-9. PubMed ID: 6075111
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of aminazine on the blood flow in the myocardium].
    Gurkovskaia AV
    Fiziol Zh; 1968; 14(1):44-50. PubMed ID: 5759669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative effect of erychroside and strophanthin on the intensity of coronary blood flow].
    Liubetskaia ZhA; Bezruk PI; Angarskaia MA
    Farmakol Toksikol; 1966; 29(2):180-3. PubMed ID: 6000341
    [No Abstract]   [Full Text] [Related]  

  • 6. [The action of beta-oxy-gamma-aminobutyric acid on the tonus of the coronary vessels and the volumetric velocity of blood circulation].
    Boroian RG
    Zh Eksp Klin Med; 1967; 7(3):6-12. PubMed ID: 5620043
    [No Abstract]   [Full Text] [Related]  

  • 7. A method for studying coronary flow in the cat in situ.
    Górka Z
    Acta Med Pol; 1971; 12(1):39-46. PubMed ID: 5545222
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remarks on the method of studying coronary blood flow in situ in cats].
    Banaszkiewicz W
    Acta Physiol Pol; 1966; 17(5):871-4. PubMed ID: 5970772
    [No Abstract]   [Full Text] [Related]  

  • 9. Total and nutritional coronary flow.
    Tillich G; Mendoza L; Bing RJ
    Circ Res; 1971 Jan; 28():Suppl 1:148+. PubMed ID: 5541113
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of heparin coating of coronary stents and ex vivo efficacy of different doses of acetylsalicylic acid and ticlopidine in a pulsed floating model of recirculating human plasma.
    Brockmann MA; Gutensohn K; Bau J; Kuehnl P; Meinertz T; Nienaber C; Beythien C
    Platelets; 2002 Dec; 13(8):443-9. PubMed ID: 12487777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of coronary arterial thrombosis with the factor Xa inhibitor rTAP in a canine electrolytic injury model.
    Lynch JJ; Sitko GR; Lehman ED; Vlasuk GP
    Thromb Haemost; 1995 Aug; 74(2):640-5. PubMed ID: 8585000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current challenges of anticoagulant treatment.
    Ginghină C; Giuşcă S; Serban M; Popescu BA; Jurcuţ R; Uscăţescu V
    Rom J Intern Med; 2007; 45(3):221-7. PubMed ID: 18333353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of halothane on the coronary blood flow].
    Banaszkiewicz W; Biczysko R
    Pol Tyg Lek; 1969 Apr; 24(14):512-5. PubMed ID: 5788341
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of some anticoagulant drugs on granulocyte capillary migration].
    Puppo F; Corsini G; Zavarise GM
    Boll Soc Ital Biol Sper; 1980 Apr; 56(7):662-5. PubMed ID: 6778489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: efficient use of heparin as an anticoagulant in blood gas studies.
    Stach PE
    Am J Hosp Pharm; 1975 May; 32(5):455. PubMed ID: 1146809
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin is an unsuitable anticoagulant for the detection of plasma ammonia.
    Wannasilp N; Sribhen K; Pussara N; Hwanpuch T; Wangchaijaroenkit S; Opartkiattikul N
    Clin Chim Acta; 2006 Sep; 371(1-2):196-7. PubMed ID: 16678809
    [No Abstract]   [Full Text] [Related]  

  • 20. Choice of anticoagulant can influence the analysis using fluorescence in situ hybridization of fetal cells enriched from maternal blood.
    Brombacher V; Kiefer V; Troeger C; Vial Y; Minderer S; Holzgreve W; Hahn S
    Prenat Diagn; 2000 Mar; 20(3):257-9. PubMed ID: 10719334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.